ERAS Competitors & Alternatives
Compare Erasca Inc with similar stocks in the same industry
Biotechnology
ERAS
Main Stock$17.90
Tradestie Score
59
Market Cap
$626.91M
Analyst Upside
+17.3%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$107.49
|
$6.64B | - | 55 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$135.98
|
$6.38B | - | 58 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$25.75
|
$6.03B | - | 45 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$50.63
|
$6.02B | - | 50 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.94
|
$5.95B | - | 58 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$228.28
|
$5.92B | - | 51 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$55.01
|
$5.80B | 20.0 | 59 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$363.44
|
$5.20B | 49.0 | 59 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$57.03
|
$4.94B | - | 63 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$81.33
|
$4.93B | - | 53 | Compare |
More ERAS Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry